“The lotus leaf has given us a wonderful example of a self-cleaning system, designed by nature. ”

– Queen's chemist Dr. Guojun Liu on his amphiphobic materials


Inventors and their innovations recognized by PARTEQ

Awards honour technology advancements in health, 
nanomaterials and green chemistry 

Dec. 6, 2012

KINGSTON, ON – Innovations in cancer treatments, lighter, stronger metals, and a promising suite of green chemical alternatives have earned special recognition awards from PARTEQ Innovations.

The discoveries, made by researchers at Queen’s University and Royal Military College, were honoured as part of PARTEQ’s celebration marking 25 years of advancing university discoveries to market. 

Laser welding technology earns Atherton Entrepreneurship Award

January 24, 2012

KINGSTON, ON -- A breakthrough optical measurement technology for laser cutting developed by two Queen’s physicists is the winner of this year’s Atherton Entrepreneurship Award.

The technology, discovered by principal investigator Dr. James Fraser and doctoral candidate Paul Webster, solves a significant problem inherent in the use of lasers in automated industrial welding, drilling and machining. The researchers’ discovery opens broad new avenues for the use of high-power lasers in both the manufacturing and eventually the medical sector.

Queen’s research sheds light on mechanism linked to the development of aggressive prostate cancer

January 26, 2011

KINGSTON, ON --Researchers at Queen’s University have identified a possible cause for the loss of a tumor-suppressor gene that plays a critical role in prostate cancer.

The loss of this gene, known as PTEN, has been associated with the development of more aggressive forms of the disease. 

Queen's-based clinical trial will test effectiveness of century-old heart drug on prostate cancer

April 26, 2012

KINGSTON, ON - A clinical trial led by two Queen's University researchers using a century-old heart drug could have a game-changing impact on the way cancers are treated. The Phase 2 clinical trial, recently approved by Health Canada, will study the effectiveness of nitroglycerin on prostate cancer. If successful, the researchers say the study could not only point to a radically new way to treat patients in the early stage of the disease; it could also stimulate further study of this approach for other types of cancer.

Greener chemical processes, potential treatments for cancer and Alzheimer’s among PARTEQ technologies awarded patents in 2011-2012

May 8, 2012

KINGSTON, ON -- A Queen's University chemistry innovation that was recognized by the Canadian Chemical News as one of the "Top 20 Canadian chemical discoveries of the past 100 years" has been issued its first U.S. patent.

Obstetrician’s low-tech tool inspires smartphone app that benefits mothers, babies and physicians

May 9, 2012

KINGSTON, ON -- A low-tech cardboard wheel used for decades by physicians to calculate pregnancy delivery dates has inspired the creation of a novel iPhone app with the potential to improve the health of new mothers – while also changing medical practice.

Developed by Dr. Graeme Smith, a Kingston General Hospital obstetrician, Maternelle is a post-pregnancy tool that, for the first time, focuses on the health of new mothers as well as their babies.

BKIN Technologies Ltd. partners with Toronto institutions in pioneering study

BKIN logo

Robotics and virtual reality pair with BOTOX® to target post-stroke spasticity

Friday, June 8, 2012

KINGSTON/TORONTO, ON – An unusual combination of robotics, virtual reality and BOTOX®, a naturally occurring toxin widely used in cosmetic procedures, may hold the key to more effectively addressing one of the most debilitating effects of stroke. That’s the aim of a $750,000 research project being conducted by an internationally recognized team of Canadian researchers.


Subscribe to RSS - 2012